Navigation Links
Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

93 Percent of Nucleoside-Naive Chronic Hepatitis B e-Antigen (HBeAg)-Negative Patients Achieved Undetectable Viral Load by Week 48 of Re-Treatment

PRINCETON, N.J., April 13, 2007 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company today announced data from a cohort of nucleoside-naive HBeAg-negative chronic hepatitis B patients (ETV-027/901, n=99). These data showed that patients who experienced recurrent levels of hepatitis B virus in the blood after interruption of treatment with BARACLUDE(R) (entecavir) achieved viral suppression and liver enzyme (ALT) normalization when re- treated for 48 weeks with BARACLUDE. The study results were presented at the 42nd Annual Meeting of the European Association for the Study of Liver Diseases (EASL) in Barcelona, Spain.

In this cohort, 93 percent of patients who were re-treated with BARACLUDE had undetectable viral load - the level of the hepatitis B virus in the blood - (HBV DNA <300 copies/mL, measured by a common assay - polymerase chain reaction or PCR) and 83 percent achieved liver enzyme normalization (ALT less than or equal to 1xULN) after 48 weeks of therapy.

"This study showed that when treated again with BARACLUDE for 48 weeks, patients achieved responses similar to those seen prior to treatment interruption, with safety results consistent with previously reported experience," said Hakan Senturk, MD, of the Ist.Univ.Cerrahpasa Tip Fak, Istanbul, Turkey.

No deaths or treatment discontinuations due to adverse events were reported in this cohort. The most common adverse events occurring in greater than 10 percent of patients were abdominal pain, fatigue, upper respiratory tract infection, nasopharyngitis, increased ALT, arthralgia, and headache.

About the Nucleoside-Naive HBeAg-Negative BARACLUDE(R) (entecavir) Re- Treatment Cohort

This analysis evaluated BARACLUDE(R) (entecavir) in nucleoside-naive chronic HBeAg-negative patie
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
2. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
3. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
7. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
8. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
9. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
10. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
11. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
Post Your Comments:
(Date:3/3/2015)... Calif. , March 3, 2015 /PRNewswire/ ... Council today recognized world-class manufacturing companies and ... Manufacturing Leadership Awards. Logo - ... world of intensifying global competition and accelerating, ... have distinguished themselves by embracing breakthrough innovation ...
(Date:3/3/2015)... 03, 2015 Research and Markets ... the "Telemedicine and Mobile Healthcare Solutions, Services, ... 2020" report to their offering. ... all terms that pertain to the use of ... remote clinical/non-clinical healthcare services. They form the ecosystem ...
(Date:3/3/2015)... Israel , March 3, 2015 /PRNewswire/ ... the "Company"), an Israeli biopharmaceutical company primarily ... for inflammatory and gastrointestinal diseases, including gastrointestinal ... , RedHill,s Chief Business Officer, will be ... online event, on Thursday, March 5, 2015, ...
Breaking Medicine Technology:2015 Manufacturing Leadership Award Winners Announced 22015 Manufacturing Leadership Award Winners Announced 32015 Manufacturing Leadership Award Winners Announced 42015 Manufacturing Leadership Award Winners Announced 52015 Manufacturing Leadership Award Winners Announced 6Global Telemedicine and Mobile Healthcare Solutions, Services, and Devices: Market Analysis and Forecasts 2015 - 2020 2Global Telemedicine and Mobile Healthcare Solutions, Services, and Devices: Market Analysis and Forecasts 2015 - 2020 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 2RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 4
... Pa., Aug. 17, 2011 Endo Pharmaceuticals (Nasdaq: ... program and collaboration related to the development of axomadol. Endo ... United States and Canada from Grunenthal in February 2009. ... management, Endo remains committed to the development and commercialization of ...
... IRVINE, Calif., Aug. 17, 2011 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today that Judge Tanya Walton Pratt ... of Indiana in Indianapolis has issued a Markman ruling in ... Cook Medical. In a Markman ruling, the ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol 2Endologix Announces Favorable Markman Ruling in Cook Patent Litigation 2
(Date:3/3/2015)... (PRWEB) March 04, 2015 ... facilities design and construction event for New England, ... Massachusetts announced key building envelope related workshops. Sessions ... Workshops include: , Curtain Walls for ... many health care and laboratory facilities are often ...
(Date:3/3/2015)... March 03, 2015 NOVAtime Technology, ... enterprise Time and Attendance / Workforce Management solutions, ... NOVAtime SaaS Workforce Management / Time and ... attendance processes. , Since 2004, Innovative Services’ ... disabilities with the best quality of life. The ...
(Date:3/3/2015)... Longtime parent visionary and inspiring new father, ... for a candid interview on the surrogacy process ... exhilarating revelation of his magical surrogacy journey — detailing ... to the birth of his precious twin girls. ... and Founder of CARE stated, “We are committed to ...
(Date:3/3/2015)... Il. (PRWEB) March 03, 2015 The ... is set to reveal the world’s first fully integrated ... are breathing and controls an air purifier to remove ... user informed, and in control, via phone, tablet or ... purifiers in over 50 countries worldwide, will unveil its ...
(Date:3/3/2015)... In March, 1% for the Planet , ... a new campaign, “Know Your Source,” which calls for consumers ... in their quest for ingredient awareness and better business practices. ... members and partners, including King Arthur Flour, Good Culture, Farm ... awareness for food as an environmental issue, with a focus ...
Breaking Medicine News(10 mins):Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 2Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 3Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 4Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 5Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 6Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 3Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 3Health News:Smart sensor and air purifier interconnect to track and trap dust, pollen and dangerous particles in home and workplace air 2Health News:1% For the Planet Asks Consumers to “Know Your Source” 2
... University in US are offering new insight into how ... ,Research from Brandeis University, which has been ... much needed insights into the probable shaping of the ... have provided new evidence towards the mechanisms that affect ...
... only when they affect only the diseased organs or cells ... to direct microcapsules into cancer cells and release their contents ... in releasing a substance into the tumour cell. They did ... directing it into the tumour cells where it gets “unpacked” ...
... improve quality of care, say researchers in this ... recently recommended //certification of doctors to strengthen professional ... in the United States that allows doctors to ... standards required for licensing purposes. Certified status must ...
... There are about three severe, potentially fatal genetic diseases ... can rupture in pregnancy and labor or even lesser ... blood vessel surgery and other approaches can be helpful, ... when they're offered. ,Now a large follow-up ...
... University researcher says that some religious activities may promote ... take notice and help their// community deal with the ... nation of gluttony and obesity, and churches are a ... professor of sociology who has studied religion and body ...
... restore healthy glucose levels and normal insulin action in obese ... published in the August 25 issue of Science and was ... (HSPH). ,Type 2 diabetes - 90 to 95 ... million people in the United States, and causes some 200,000 ...
Cached Medicine News:Health News:Research Reveal A New Angle On Neural Circuits. 2Health News:Microcapsules target cancer cells 2Health News:Microcapsules target cancer cells 3Health News:Certification of UK Doctors Would Improve Quality of Care 2Health News:Scientists Review Loeys-Dietz Syndrome in the Largest Ever Study to date 2Health News:Scientists Review Loeys-Dietz Syndrome in the Largest Ever Study to date 3Health News:Religious Activities Could Promote Obesity 2Health News:Religious Activities Could Promote Obesity 3Health News:Religious Activities Could Promote Obesity 4Health News:Two Chemical Compounds Restore Healthy Glucose Levels In Obese Mice 2Health News:Two Chemical Compounds Restore Healthy Glucose Levels In Obese Mice 3
The Auto Suture&trade ENDO RETRACT&trade Maxi instrument has application in a variety of general, thoracic, gynecologic, urologic, and endoscopic procedures for temporary retracting of tissue and sma...
... Featured Products are kept ... and are offered as ... regular or extra long ... with insulation, flush ports, ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: